Winter, S. F., Vaios, E. J., Muzikansky, A., Martinez-Lage, M., Bussière, M. R., Shih, H. A., … Dietrich, J. (2020). Defining Treatment-Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment-Induced Necrosis. The Oncologist, 25(8), e1221–e1232. https://doi.org/10.1634/theoncologist.2020-0085

Winter, Sebastian F., Eugene J. Vaios, Alona Muzikansky, Maria Martinez-Lage, Marc R. Bussière, Helen A. Shih, Jay Loeffler, et al. “Defining Treatment-Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment-Induced Necrosis.” The Oncologist 25, no. 8 (August 1, 2020): e1221–32. https://doi.org/10.1634/theoncologist.2020-0085.

Winter SF, Vaios EJ, Muzikansky A, Martinez-Lage M, Bussière MR, Shih HA, et al. Defining Treatment-Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment-Induced Necrosis. The Oncologist. 2020 Aug 1;25(8):e1221–32.

Winter, Sebastian F., et al. “Defining Treatment-Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment-Induced Necrosis.” The Oncologist, vol. 25, no. 8, Oxford University Press (OUP), Aug. 2020, pp. e1221–32. Crossref, doi:10.1634/theoncologist.2020-0085.

Winter SF, Vaios EJ, Muzikansky A, Martinez-Lage M, Bussière MR, Shih HA, Loeffler J, Karschnia P, Loebel F, Vajkoczy P, Dietrich J. Defining Treatment-Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment-Induced Necrosis. The Oncologist. Oxford University Press (OUP); 2020 Aug 1;25(8):e1221–e1232.